baber/WOPTO huggingface dataset:
Patent DK-167665-B1 (DK)
Inventor: PIEPER HARTWIG
IPC: B41N6/02
Filed: 1987-10-20
Granted: 1993-12-06
Abstract: In the process, the relief printing form consists of an underlay (U) made of an elastomeric material, a relief layer (P) made of a mixture photocrosslinked by irradiation with actinic light, which before photocrosslinking contained a mixture of 50 - 99% by weight of an elastomer and 1 - 50% by weight of at least one photopolymerisable olefinically unsaturated monomer substantially compatible with the elastomer, as well as, between the underlay (U) and the relief layer (P) and attached to each by thin layers of adhesive, an intermediate layer (Z) which is insoluble in both the developer solvent used to produce the relief and in the printing ink solvents and is impermeable to them, and where the side of the underlay (U) facing away from the intermediate layer (Z) is provided with an adhesive layer transparent to actinic light, which on the one hand is firmly attached to the underlay (U) and on the other hand possesses an adhesive force of 1 - 6 N/25 mm, the relief printing form thus being attached to the printing cylinder.
Patent DK-175635-B1 (DK)
Inventor: S LINSLEY PETER
IPC: C12N15/00
Filed: 1987-11-18
Granted: 2004-12-27
Abstract: Novel hybridoma cell lines producing monoclonal antibodies reactive with purified mucin antigens from normal and tumor sources are generated using mucins, including purified mucins from tumor sources. Epitopes on mucin antigens from normal and tumor sources are demonstrated to be distinct, using these new antibodies. The antibodies may be useful alone or in combination, in the diagnosis and treatment of cancer including malignancies of the breast and lung.
Patent FI-104195-B1 (FI)
Inventor: SILENIUS PETRI
IPC: D21B1/00
Filed: 1996-05-03
Granted: 1999-11-30
Abstract: The invention relates to a procedure for determining a quantity dependent on the rate of diffusion in the fibre wall for diffusion occurring through it, in which procedure a diffusible tracer is introduced into the fibres under measurement, the fibres are suspended in an aqueous phase and the tracer concentration is determined after a certain time has elapsed since the time of suspension of the fibres, and the quantity dependent on the rate of diffusion is calculated on the basis of the concentration and time. <??>In addition, the invention relates to a procedure for determining the proportion of secondary fibre in a fibre suspension containing primary fibre and secondary fibre, in which procedure virtual diffusion coefficients are determined in the fibre wall for diffusion taking place through it in at least two fibre suspensions for which the proportions of primary and secondary fibre are known and in a fibre suspension under measurement, and that the proportion of secondary fibre in the suspension under measurement is estimated by assuming that the diffusion coefficient depends mainly linearly on the proportion of primary and secondary fibre in the fibre suspension. <IMAGE>
Patent IE-44684-B1 (IE)
Title: Process for producing methyl 3-2(2-quinoxylinylmethylene) carbazate-n1,n4-dioxides
IPC: A61P31/04
Filed: 1977-05-20
Abstract: The carbazates of formula I are obtained by reacting the quinoxaline N<1>,N<4>-dioxides carrying in position 2 a chloromethyl or bromomethyl group with one to two equivalents of an alkali metal carbonate and one to two equivalents of a hydrazine of formula R''NH-NH-COOCH3 at a temperature of between 75 and 85 DEG C and in an inert solvent. This hydrazine is prepared by reaction of methyl carbazate with a corresponding acid anhydride or sulphonyl halide which introduces the radical R''. The meaning of the symbols is explained in Claim 1. The compounds of formula I are strong antibacterial agents.
Patent IE-37892-B1 (IE)
Title: Antibiotic a-2315 and process for preparation thereof
IPC: A61K35/74
Filed: 1973-07-09
Abstract: 1433417 Antibiotic A-2315 ELI LILLY & CO 30 July 1973 [31 July 1972] 36111/73 Headings C2A and C2C The new antibiotic "A-2315" having the possible structural formula is prepared by aerobic cultivation of the organism Actinoplanes philippinensis NRRL 5462 (nov. spec.). It may be separated from the fermentation medium by conventional procedures, e.g. extraction with chloroform and purification by chromatography on silica gel. The antibiotic is stated to have antibacterial activity, in particular against gram-positive streptococci, especially those responsible for periodontal disease. It also has animal growth promoting activity and may be used to combat plant fungal infections as well as a general disinfectant.
[GB1433417A]
Patent IE-61098-B1 (IE)
Title: Herpesvirus recombinant poxvirus vaccine
Inventor: PAOLETTI ENZO
IPC: C07K14/15
Filed: 1990-04-18
Abstract: What is described is a recombinant poxvirus, such as vaccinia virus, fowlpox virus and canarypox virus, containing foreign DNA from herpesvirus. In one embodiment, the foreign DNA is expressed in a host by the production of a herpesvirus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two, particularly two or three, herpesvirus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, the barrier of maternal immunity in a newborn offspring can be overcome or avoided.
Patent IE-39870-B1 (IE)
Title: Improvements in or relating to apparatus and method for toughening glass
IPC: C03B27/00
Filed: 1974-07-03
Abstract: 1442320 Tempering glass sheets PILKINGTON BROS Ltd 11 July 1974 [20 July 1973] 34707/73 Heading C1M In the tempering of flat or bent glass sheets by quenching in a chilling liquid, an electrical sensor is located in the chilling liquid to provide a signal indicative of the heat transfer properties of the liquid. The sensor comprises a resistance wire 1 supplied from a stabilized current source 14. A voltage measuring device 13 measures the voltage drop across the wire 1, the voltage indicating the transfer properties of the liquid. As an alternative the voltage supply may be stabilized and the current measured. The heat transfer properties of the liquid are adjusted in response to the measurement by adding to the liquid mixtures of a high boiling point oil such as "Mobil Cylrex" (Registered Trade Mark) and a low boiling point additive such as toluene or carbon tetrachloride. The chilling liquid itself comprises the oil and a lower proportion of additive. As shown (Figs. 5A, 5B) toluene and carbon tetrachloride in containers 53 are fed into a mixing chamber 52. The mixing chamber is also supplied with oil from an overflow in the quenching tank 20 and a source of fresh oil 37. When the voltage derived from the measuring device 13 differs from a datum voltage supplied by a manually adjustable set point potentiometer, a pump 62 is activated to supply the enriched additive/oil mixture to the quench tank.
[GB1442320A]
Patent IE-34744-B1 (IE)
Title: Novel hydroxycrotonic acid derivatives,their preparation and compositions containing them and novel intermediates for the preparation of the same
IPC: C07C315/04
Filed: 1970-11-17
Abstract: 1322370 Analgesic &c medicines DR KARL THOMAE GmbH 16 Nov 1970 [17 Nov 1969 29 Sept 1970 (4)] 54474/70 Heading A5B [Also in Division C2] Pharmaceutical compositions having antiphlogistic, analgesic and antitussive activity and an effect on the prolongation of bleeding time comprise, as active ingredient, a 4-[biphenylyl- (4)]-4-hydroxycrotonic acid of the general formula: wherein each of R 1 , R 2 and R 3 is a hydrogen atom or one or two of R 1 , R 2 and R 3 is/are selected from halogen atoms and C 1-4 alkyl, C 1-4 hydroxyalkyl, nitro, amino, acetylamino, cyano, carbethoxy, hydroxy, methoxy, methylthio, methylsulphinyl, methylsulphonyl and optionally methyl-substituted carbamoyl groups and the other(s) is/are a hydrogen atom or hydrogen atoms, or a physiologically compatible base addition salt thereof, in association with a pharmaceutical carrier or excipient and, optionally, a further physiologically active ingredient, e.g. p-ethoxy-acetanilide. They may be administered orally, rectally or parenterally as granules, tablets, coated tablets, capsules, syrups, emulsions, suspensions, drops, ampoules or suppositories. (From GB1322370 A) [FR2073368A1]
Patent IE-33616-B1 (IE)
Title: Process and apparatus for the production of fibrillated material
IPC: B29B15/00
Filed: 1969-11-04
Abstract: 1,274,478. Polymerisation apparatus. SOLVAY & CIE. 9 Dec., 1969 [13 Dec., 1968], No. 60067/69. Heading B1X. [Also in Division C3] Apparatus for the production of fibrillated polyethylene comprises reactor 1 provided with a stirrer, one or more inlets 2, 3, 4 for feeding ethylene, catalyst and diluent, a gas-removing enclosure 6 also having a stirrer and connected to reactor I by a channel which has an expansion valve 5, heating means for heating the suspension of polymer after removal of gas therefrom, the heating means comprising polymer liquefying vat 9 and/or heat exchanger 13, and being connected to the gas-removing enclosure 6 by a channel, extrusion means 15 fed from the heating means and extruding into enclosure 18 for instantaneously vaporizing the diluent, the product then leaving at 20, and optionally filtration means 14, and pressure control means 16, 17.
[GB1274478A]
Patent IE-39659-B1 (IE)
Title: Method of manufacturing a milk chocolate
IPC: A23G1/00
Filed: 1974-08-08
Abstract: 1425337 Making chocolate CADBURY Ltd 7 Aug 1974 [17 Aug 1973] 38960/73 Heading A2B Milk chocolate is made by heating an aqueous sugar solution to 250-320F and mixing the resultant hot solution with milk powder and processing the resultant mixture with other chocolate making ingredients to form milk chocolate. The mixing may be effected in the presence of butter fat, cocoa mass and/or cocoa powder and up to 5% by wt. of the total sugar may be a reducing sugar.
[GB1425337A]
Patent IE-53421-B1 (IE)
Title: A semiconductor read only memory device
IPC: G11C17/12
Filed: 1981-07-30
Abstract: A semiconductor read only memory device comprises bit lines (BLo to BLn), word lines (WLo to WLm), a load transistor (QL), a multiplexer (MPX) including a plurality of transistors (Qxo to Qxn), a memory cell array (MCA) in which each memory cell has one transistor (Qoo TO Qmn) having a gate connected to one of the word lines (WLm) and corresponding to one of the bit lines (BLn) connected to said transistors of said multiplexer (MPX), a gate transistor (QG) inserted between said load transistor (QL) and said multiplexer (MPX), and a gate voltage control circuit (CNT) for selectively providing a higher level signal and a lower level signal.
Patent IE-45513-B1 (IE)
Title: Improvements relating to stay rings for the spiral casingsof rotary hydraulic machines
IPC: F03B3/18
Filed: 1977-09-15
Abstract: A stay vane ring for the spiral casing of a rotary hydraulic machine comprises two axially spaced-apart ring members disposed coaxially about the machine axis and a plurality of axially extending stay vanes connected between the ring members. Each ring member comprises a substantially cylindrical ring of metal plate and the axial ends of the stay vane plates are extended in axial direction on both sides of said cylindrical plate ring of the ring members at least substantially all the way out to the most distant circular edge of the cylindrical plate ring so that a cross-joint is formed between each stay vane plate and the cylindrical plate ring of each ring member. At each such cross-joint the stay vane plate and the cylindrical plate ring are welded to each other.
Patent IE-45589-B1 (IE)
Title: Improvements in or relating to quartz-controlled high-frequency oscilliators
IPC: H03L7/20
Filed: 1977-09-16
Abstract: 1529549 Automatic frequency control SIEMENS AG 26 July 1977 [17 Sept 1976] 31203/77 Heading H3A In an a.f.c. loop for locking a controlled oscillator 4 to a crystal controlled reference source 1, the output from the reference source 1 is fed via a divider or multiplier 2 to a mixer 41 in the controlled oscillator and the output from the mixer is compared with a harmonic or subharmonic of the reference signal in a comparator 6 to produce the required control signal for the oscillator 4.
Patent IE-61994-B1 (IE)
Title: Process for preparing self-supporting bodies and products made thereby
Inventor: WHITE DANNY RAY
IPC: C04B35/65
Filed: 1988-07-15
Abstract: Self-supporting bodies are produced by reactive infiltration of a parent metal (10) into boron carbide (12) typically resulting in a composite comprising a boron-containing compound and metal. The mass to be infiltrated may contain one or more inert fillers (14) admixed with the boron carbide (12) to produce a composite by reactive infiltration, which composite comprises a matrix of metal and boron-containing compound embedding the filler (14). The relative amounts of reactants and process conditions may be altered or controlled to yield a body containing varying volume percents of ceramic, metal and/or porosity.
Patent IE-57303-B1 (IE)
Title: Extruded plastics profile for refrigerators or the like
IPC: F25D23/08
Filed: 1986-08-21
Abstract: An extruded profile of synthetic material for refrigerators, refrigerating compartments, coolboxes or the like, is characterised in that it has two leg regions arranged at right angles to one another and in that one leg region has a groove which is open to the outside of the leg region. Preferably, the other leg region has at its free end a rearwardly open recess for a wall panel of the refrigerator or the like. <IMAGE>
Patent IE-46436-B1 (IE)
Title: Clavulanic acid ethers
IPC: C07D503/00
Filed: 1977-12-09
Abstract: A process for the preparation of a compound of the formula (1): (I) or a salt or ester thereof wherein R is a methyl or ethyl group which process comprises the reaction of clavulanic acid or a salt or ester thereof with an oxonium salt of the formula (II): R3O? X.THETA. (II) wherein R is a methyl or ethyl group and X.THETA. is an anion and thereafter if desired performing one or both of the following reactions: (a) converting the thus formed ester into the acid or salt and (b) converting the thus formed acid or salt into an alternative ester or alternative salt. The compounds of formula (I) have utility as additives to enhance the effectiveness of penicillins and cephalosporius. The novel process is generally convenient, safer and often higher yielding than known processes.
Patent IE-46130-B1 (IE)
Title: Teat cup liners
IPC: A01J5/00
Filed: 1977-12-30
Abstract: A teat cup liner is formed at the tube end with a series of external elongated projections of elastic material extending lengthwise of the liner and distributed evenly around the circumference of the tube end to provide it with a shock absorber.
Patent IE-60556-B1 (IE)
Title: Herbicidal composition
IPC: A01N35/10
Filed: 1987-10-13
Abstract: A herbicidal composition comprising a herbicidal cyclohexane dione of partial structure (I) : and a surfactant having terminal hydroxy groups in which the hydroxy groups have been replaced by organic blocking groups.
Patent IE-69577-B1 (IE)
Title: Method of gene mapping
Inventor: LIVAK KENNETH JAMES
IPC: C12Q1/68
Filed: 1988-09-27
Abstract: The method described characterizes each DNA segment to be mapped by cleaving it to produce DNA fragments which are then end labeled with a reporter(s) specific to the end nucleotides of each fragment. The labeled fragments are again cleaved to produce short fragments which are separated according to size. The short fragments are analyzed as to reporter identity and size which is indicative of the character of each fragment. By derivatizing the cleaved ends of the primary cleaved fragments, the labeling may be delayed until the second cleavage. Prior to labeling the derivatized fragments, all underivatized fragments are removed, the derivatized fragments being immobilized.
Patent IE-59102-B1 (IE)
Title: Antibiotic isoxazole derivatives, their production and use
IPC: C07D413/04
Filed: 1985-12-17
Abstract: The compounds of the formula: <CHEM> wherein R<1> is amino or an organic residue bonded through nitrogen; R<2> is carboxy or a group derivable therefrom; X is hydrogen, methoxy or formylamino, provided that when R<1> is acetylamino or amino and X is hydrogen, R<2> is not paranitrobenzyloxycarbonyl or benzhydryloxycarbonyl or salts thereof exhibit excellent antimicrobial activity, and are utilized as antimicrobial agents.
Patent IE-61132-B1 (IE)
Title: Device for fixing a tube which passes through a wall
Inventor: MASINI JEAN JACQUES
IPC: B01J3/00
Filed: 1988-12-13
Abstract: The invention relates to a device for fixing tubes passing through a wall, more particularly tubes of glass or quartz containing ultraviolet emitters and entering a pressure reactor in which radical chlorination processes are performed. The end of the tube (1) outside the chamber forms, in combination with a component made of a flexible material (7, 8), a ball (10, 11) and the point where the tube passes through the wall is sealed by a lip seal (3, 4).
Patent IE-64541-B1 (IE)
Title: Ventilation tile
Inventor: HESKETH MARK LAWRENCE
IPC: E04D1/30
Filed: 1989-12-21
Abstract: A roof tile construction includes a ventilation tile having pliable portions provided by a membrane of PVC (polyvinyl chloride) which is readily deformable to complement the shapes and configurations of adjacent roof tiles, whereby gaps between the headlap, side-lock and tail portions of tiles immediately adjacent the ventilation tile are substantially closed. The ventilation tile also includes a rigid body portion for supporting the membrane, the body portion being generally of planar configuration and being provided with adapter means for accommodating ventilation means such as a ventilation cap, or a soil pipe. The membrane is also of generally planar configuration and includes a headlap portion, oppositely disposed side-lock portions and a tail portion which extends beyond the rigid body portion. The tail portion is provided with an adhesive coating and with stiffening means in order to secure the tail portion to and maintain conformity of the tail portion with the profile of the headlap portion of an adjacent tile, and is also provided with corrugations extending across the width thereof. A depending wall portion at the headlap portion of the rigid body portion assists in locating the ventilation tile on a roof batten.
[US5053266A]
Patent IE-69844-B1 (IE)
Title: Microbiological process for the preparation of 6-hydroxypicolinic acid
Inventor: KIENER ANDREAS
IPC: C12R1/38
Filed: 1992-01-29
Abstract: The process starts from picolinic acid and/or the salts thereof, and the concentration of picolinic acid and/or the salts thereof is chosen so that the 6-hydroxypicolinic acid undergoes no further metabolism. 
<??>This process is carried out either using microorganisms of the genus Pseudomonas, Bacillus, Alcaligenes or Rhodotorula or with biomass which utilises picolinic acid, which microorganisms or biomass grow with picolinic acid as the sole source of carbon, nitrogen and energy.
Patent LU-102362-B1 (LU)
Title: Verfahren und Vorrichtungen zur intuitiv-unbewussten Lösungsfindung
Inventor: STUTH ANDRÉ
IPC: G06Q10/06
Filed: 2020-12-24
Granted: 2022-06-27
Abstract: Die vorliegende Erfindung schafft ein Verfahren zur lernfähigen Steuerung eines Prozesses oder eines Steuerungssystems, insbesondere zum automatisierten Auffinden der Lösung eines Problems oder einer Aufgabenstellung, insbesondere unter Erhebung und/oder Nutzung von prozeduralem Ereigniswissen, vorgesehen, umfassend: Definieren einer Aufgabenstellung, welche darin besteht, eine konkrete Start-Objektsituation rnithilfe einer Ereignissequenz in eine konkrete Ziel-Objekt Situation zu überführen, Lesen einer Datenbank zwecks Suche einer passenden Lösung in Form einer Ereignissequenz, welche geeignet ist, die Aufgabenstellung zu lösen, wobei die Datenbank geeignet ist, mindestens folgende Größen einander zuzuordnen: einen Bezeichner einer möglichen Start-Objektsituation, Bezeichner der beteiligten Objektarteneinen, Bezeichner einer möglichen Ziel-Objektsituation, Bezeichner der beteiligten Objektarten, eine Information zu einer Ereignissequenz, wobei die Ereignis-Sequenz dazu geeignet ist, die mögliche Start-Objektsituation in die mögliche Ziel-Objektsituation zu überführen, Auswählen einer Ereignissequenz als eine zur Aufgabenstellung passenden Lösung in der Datenbank, wenn eine zur Aufgabenstellung passende Lösung gelesen wurde, oder Bilden einer neuen Ereignissequenz, wenn eine zur Aufgabenstellung passende Lösung nicht gelesen wurde, als n-Konkatenation aus den vorhandenen Ereignissequenzen, umfassend die folgenden Schritte: Lesen der Datenbank zwecks Suche mindestens einer ersten und einer n-ten Ereignissequenz, insbesondere Suche von Ereignissequenzen von einer ersten bis zu einer n-ten Ereignissequenz, wobei n eine natürliche Zahl bezeichnet und die erste Ereignissequenz dazu geeignet ist, die mögliche Start-Objektsituation in eine erste Intermediär-Objektsituation zu überführen und für alle natürlichen Zahlen, für die gilt 1 < k < n, die k-te Ereignis-Sequenz dazu geeignet ist, eine (k-1)-te Intermediär-Objektsituation in eine k-te Intermediär-Objektsituation zu überführen, und die n-te Ereignis-Sequenz dazu geeignet ist, eine (n-1)-te Intermediär-Objektsituation in die mögliche Ziei-Objektsituation zu überführen, ggfs. Ablegen einer neu entstandenen Ereignissequenz als n-Konkatenation in der Datenbank, wobei die neue konkatenierte Ereignissequenz dazu geeignet ist, die mögliche Start-Objektsituation in die mögliche Ziel-Objektsituation zu überführen, wobei die Ereignissequenzen zwischen zwei Objektsituationen dabei in jeder beliebigen Programmier- oder Beschreibungssprache initial erhoben und gespeichert werden können, insbesondere in einer beliebigen, aber einheitlichen Programmier- oder ßeschreibungssprache. Die Erfindung betrifft des Weiteren entsprechenden Vorrichtungen. Die Erfindung erstreckt sich zudem auf entsprechende Computerprogramme und Datenträger, welche solche Computerprogramme enthalten, sowie die Übertragung solcher Computerprogramme über ein Computernetzwerk wie beispielsweise das Internet.
Patent LU-500796-B1 (LU)
Title: Transgenic Strain of Metarhizium anisopliae and Preparation Method and Application thereof
Inventor: ZHAO HAIZHENG
IPC: C12N15/80
Filed: 2021-10-27
Granted: 2022-04-27
Abstract: The invention discloses a transgenic strain of Metarhizium anisopliae, preparation method and application thereof, which is a recombinant strain constructed by Metarhizium anisopliae gene and exogenous subtilisin-like protease (SLP) Prla gene. The principle of Metarhizium anisopliae transgenic strain is as follows: basing on Metarhizium anisopliae, and then using Pgpd as a strong promoter and TTrpC as a terminator as well as Basta as a screening marker; next, constructing a subtilisin-like protease Pr1al overexpression box by using a fusion PCR method, preparing fungal protoplasts, and then carrying out genetic engineering transformation by using a CaCl2-PEG method; finally, randomly inserting the overexpression box into the genome of Metarhizium anisopliae for overexpression. The Metarhizium anisopliae transgenic strain has some advantages of good killing effect on Blattella germanica, strong toxicity and effectively controlling Blattella germanica population in a short time.
Patent NO-301578-B1 (NO)
Inventor: OHMURA TADAYOSHI
IPC: A61K9/52
Filed: 1990-03-09
Abstract: A coating material for controlling drug release, useful for long acting formulations (e.g. for once-a-day administration), and a long acting granular composition comprising a drug (especially one conventionally difficult to prepar in long acting form) coated with the coating material. This composition may be mixed with other granular drug formulations. The drug-release controlling coating material may comprise, in a specific ratio, specific water-insoluble and low water-permeability polymer and two materials differing from each other in the pH-dependency of their solubility (pH-dependent polymer materials).